The Department of Health has been ordered to reconsider the split of a R12.6 billion tender for SA’s once-a-day antiretroviral pill after concluding one major manufacturer was ‘arbitrarily’ excluded on price.
Nadzeya Haroshka/Getty Images
Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, and empowerment. You can only trial once.